tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sean Lee, 57 are a BUY (90.48%), 6 are a HOLD (9.52%).
Analyst Sean Lee, carries an average stock price target met ratio of 31.71% that have a potential upside of 46.13% achieved within 97 days. Previously, Sean Lee worked at HCWAINWRIGHT.
Sean Lee’s has documented 119 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MNPR, Monopar Therapeutics at 22-Jan-2025.
Analyst best performing recommendations are on CTSO (CYTOSORBENTS CRP).
The best stock recommendation documented was for CTSO (CYTOSORBENTS CRP) at 11/11/2024. The price target of $1 was fulfilled within 1 day with a profit of $0.16 (19.05%) receiving and performance score of 190.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$6
$3.5 (140.00%)
$12
9 months ago
(15-May-2024)
1/4 (25%)
$2.73 (83.49%)
54
Buy
$4
2 years 2 months 30 days ago
(16-Nov-2022)
1/2 (50%)
$0.72 (21.95%)
73
Buy
$12
$9.5 (380.00%)
2 years 6 months ago
(15-Aug-2022)
1/2 (50%)
$7.98 (198.51%)
308
Buy
$50
2 years 8 months 21 days ago
(26-May-2022)
0/1 (0%)
$32.3 (182.49%)
Which stock is Sean Lee is most bullish on?
Which stock is Sean Lee is most reserved on?
What Year was the first public recommendation made by Sean Lee?
